Guided self-help for functional (psychogenic) symptoms: A randomized controlled efficacy trial

Neurology

Volumn 77, Issue 6, 2011, Pages 564-572

  Sharpe, M ^a   Walker, J ^a   Williams, C ^b   Stone, J ^a   Cavanagh, J ^b   Murray, G ^a   Butcher, I ^a   Duncan, R ^c   Smith, S ^d   Carson, A ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^d NHS LOTHIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANIC; PATIENT GUIDANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF HELP; SOMATOFORM DISORDER; TREATMENT DURATION; AMBULATORY CARE; ANXIETY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST OF ILLNESS; DEPRESSION; MENTAL DISEASE; MIDDLE AGED; MULTICENTER STUDY; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER; SAMPLE SIZE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANXIETY; COGNITIVE THERAPY; COST OF ILLNESS; DATA INTERPRETATION, STATISTICAL; DEPRESSION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOPHYSIOLOGIC DISORDERS; SAMPLE SIZE; SELF-HELP GROUPS; TREATMENT OUTCOME;

EID: 80053297408     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318228c0c7     Document Type: Article

References (31)

1. Gureje O, Simon GE, Ustun TB, Goldberg DP. Somatization in cross-cultural perspective: a World Health Organization study in primary care. Am J Psychiatry 1997;154:989-995.
2. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999;354:936-939.
3. Hamilton J, Campos R, Creed F. Anxiety, depression and the management of medically unexplained symptoms in medical clinics. J R Coll Physicians Lond 1996;30:18-20.
4. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001;51:361-367.
5. Carson AJ, Ringbauer B, Stone J, McKenzie L, Warlow C, Sharpe M. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 2000;68:207-210.
6. Carson AJ, Best S, Postma K, Stone J, Warlow C, Sharpe M. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003;74:897-900.
7. Sharpe M, Stone J, Hibberd C, et al. Neurology outpatients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med 2010;40:689-698.
8. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007;69:881-888.
9. Sharpe M, Carson AJ. "Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med 2001;134(suppl): 926-930.
10. Gellatly J, Bower P, Hennessy S, Richards D, Gilbody S, Lovell K. What makes self-help interventions effective in the management of depressive symptoms? Meta-analysis and meta-regression. Psychol Med 2007;37:1217-1228.
11. Williams CJ. Overcoming Depression and Low Mood: A Five Areas Approach, 2nd ed. London: Hodder Arnold; 2006.
12. Williams CJ. Overcoming Anxiety: A Five Areas Approach. London: Hodder Arnold; 2001.
13. Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005;76(suppl 1): i13-i21.
14. Morriss RK, Gask L. Treatment of patients with somatized mental disorder: effects of reattribution training on outcomes under the direct control of the family doctor. Psychosomatics 2002;43:394-399.
15. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1756.
16. Kroenke K, Spitzer RL, Williams BW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258-266.
17. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
18. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
19. Speckens AE, Spinhoven P, Sloekers PP, Bolk JH, Van Hemert AM. A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patients. J Psychosom Res 1996;40:95-104.
20. Weinman J, Petrie KJ, Moss-Morris R, Horne R. The Illness Perception Questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health 1996;11:431-445.
21. McCullagh P. Regression models for ordinal data. J R Statist Soc Ser B Methodol 1980;42:109-142.
22. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-155.
23. Stone J, Carson A, Duncan R, et al. Symptoms 'unexplained by organic disease' in 1144 new neurology outpatients: how often does the diagnosis change at follow-up? Brain 2009;132:2878-2888.
24. Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006;166:1512-1518.
25. Escobar JI, Gara MA, Diaz-Martinez AM, et al. Effectiveness of a time-limited cognitive behavior therapy type intervention among primary care patients with medically unexplained symptoms. Ann Fam Med 2007;5:328-335.
26. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205-215.
27. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007;69:889-900.
28. Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med 2002;64:939-950.
29. Reuber M, Burness C, Howlett S, Brazier J, Grunewald R. Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res 2007;63:625-632.
30. Morriss R, Dowrick C, Salmon P, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry 2007;191:536-542.
31. Rosendal M, Olesen F, Fink P, Toft T, Sokolowski I, Bro F. A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. Gen Hosp Psychiatry 2007;29:364-373.